نتائج البحث

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.

• Authors : Motzer, Robert J; Porta, Camillo; Eto, Masatoshi ...

Subjects: Cancer Research; Oncology; Human health sciences

• Source: Journal of Clinical Oncology, JCO2301569 (2024-01-16)

تفاصيل العنوان

Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.

• Authors : Fornecker, Luc-Matthieu; Lazarovici, Julien; Aurer, Igor

Subjects: Brentuximab Vedotin; Bleomycin; Vinblastine

• Source: Journal of Clinical Oncology, 41, 327 - 335 (2023)

تفاصيل العنوان

Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma: A Feasibility Study.

• Authors : D'Hondt, Véronique; Goffin, Frédéric; Roca, Lise

Subjects: Antineoplastic Agents; Cisplatin; Adult

• Source: International Journal of Gynecological Cancer, 26 (5), 912 - 917 (2016-06)

تفاصيل العنوان

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.

• Authors : Vergote, Ignace; Scambia, Giovanni; O'Malley, David M ...

Subjects: Recombinant Fusion Proteins; Carboplatin; Paclitaxel

• Source: The Lancet Oncology, 20 (6), 862 - 876 (2019-06)

تفاصيل العنوان

What Is the Best First-Line Treatment for Young Women with Generalized Epilepsy?

• Source: Internal Medicine Alert. 9/30/2024, Vol. 46 Issue 18, p1-14. 14p.

تفاصيل العنوان

Final Analysis of KEYNOTE-826 Trial Confirms Benefit of Pembrolizumab Plus Chemotherapy in First-Line Treatment of Cervical Cancer.

• Authors : Stewart, Patricia

• Source: Oncology Practice Management. Aug2023, Vol. 13 Issue 8, p18-19. 2p.

تفاصيل العنوان

Experts call for new trials of hepatitis B drugs: evidence needed to identify first-line treatment.

• Authors : Traynor K

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepatitis B, Chronic/Hepatitis B, Chronic/Hepatitis B, Chronic/*drug therapy; Antiviral Agents/Antiviral Agents/Antiviral Agents/pharmacology

• Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2008 Dec 01; Vol. 65 (23), pp. 2184, Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Gleevec approved for first-line treatment of CML.

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy ; Piperazines/Piperazines/Piperazines/*therapeutic use

• Source: FDA consumer [FDA Consum] 2003 Mar-Apr; Vol. 37 (2), pp. 5.Publisher: Supt. of Docs., U. S. Govt. Print. Off Country of Publication: United States NLM ID: 0344327 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

Diuretics: first-line treatment for hypertension in the elderly.

Subjects: Diuretics/Diuretics/Diuretics/*therapeutic use ; Hypertension/Hypertension/Hypertension/*drug therapy; Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/therapeutic use

• Source: Harvard heart letter : from Harvard Medical School [Harv Heart Lett] 1998 Sep; Vol. 9 (1), pp. 6.Publisher: Harvard Medical School Health Publications Group Country of Publication: United States NLM ID: 9425723 Publication Model: Print Cited Medium:

تفاصيل العنوان

Cyramza plus Tarceva Approved for First-Line Treatment of Metastatic NSCLC with EGFR Mutation.

• Source: Value-Based Cancer Care. Aug2020, Vol. 11 Issue 4, p24-26. 3p.

تفاصيل العنوان